NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its first-quarter 2013 revenues increased 9 percent, driven by a 23 percent increase in royalty revenues year over year and a jump in assay sales.

Austin, Texas-based Luminex brought in total revenues of $53.2 million for the three months ended March 31, compared to revenues of $48.7 million for the first quarter of 2012. It beat the consensus Wall Street estimate for revenues of $52 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.